Molecular Imaging News and Research

RSS

PET imaging can help identify autoimmune inflammation in MS

The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation therapies for MS, say researchers introducing a study at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

14 Jun 2016

PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

Alcoholism is a devastating disorder that too often leads to a perpetual cycle of abuse. An emerging molecular imaging technique may provide a way to break that cycle.

14 Jun 2016

Novel radioimmunotherapy may help cure colorectal cancer

An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models.

14 Jun 2016

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects bone metastases in patients with advanced prostate cancer, and follow-up scans over time correlate clearly with clinical outcomes and patient survival.

8 Jun 2016

University of Arizona selects Cubresa’s NuPET scanner for cancer research

Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced that their compact PET scanner called NuPET™ for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) has been selected by the University of Arizona (UA).

From Cubresa Inc. 1 Jun 2016

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Great discoveries do come in small packages. Few know that better than Ann-Marie Broome, Ph.D., who feels nanotechnology holds the future of medicine with its ability to deliver powerful drugs in tiny, designer packages.

23 May 2016

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging.

17 May 2016

‘Together we are stronger’ - partnership at the heart of expansion plans to revolutionise medical imaging services

A number of sites across West Birmingham and Sandwell, including the new multi-million pound Midland Metropolitan Hospital opening in October 2018, are set to transform patient care for up to 530,000 people in the area.

11 May 2016

Ga-68 DOTATATE PET/CT scans more effective than current imaging standard for detecting NETS

A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors, and could significantly impact treatment management.

10 May 2016

Snapshots of NMDA receptor activation may help in novel drug design

Structural biologists at Cold Spring Harbor Laboratory and Janelia Research Campus/HHMI, have obtained snapshots of the activation of an important type of brain-cell receptor. Dysfunction of the receptor has been implicated in a range of neurological illnesses, including Alzheimer's disease, Parkinson's disease, depression, seizure, schizophrenia, autism, and injuries related to stroke.

3 May 2016

Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems

A compact PET scanner called NuPET has been commercially released for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI systems.

From Cubresa Inc. 29 Apr 2016

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

To me the most exciting aspect of pre-clinical imaging is its broad range, from very basic science up to applied science. You deal with a range of disciplines including biology, chemistry, physics, biochemistry, biophysics, cell biology and of course medicine, as the aim is the translation of research to humans.

From Bruker BioSpin Division 27 Apr 2016

Transforming MR images into body composition measurements: an interview with Olof Leinhard

Today's medical science utilizes relatively simple anthropometric measures that describe the body, such as body mass index (BMI) and waist circumference. All of these measures are approximations of the body with the intention to characterize what's inside reflecting underlying phenomena that underpin the risk for different diseases.

26 Apr 2016

Scientists discover Hobit, Blimp1 genes that fight disease-causing pathogens

Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion' - whether it's the skin, liver, lungs or the gut.

25 Apr 2016

Researchers examine neuropsychological effect in ecstasy users

Researchers from the University of Liverpool have conducted a study examining the effect ecstasy has on different parts of the brain.

19 Apr 2016

Structure of fibril protein could lead to specific targets for diagnosis, treatment of Parkinson's disease

Chemists have identified the complex chemical structure of the protein that stacks together to form fibrils in the brains of Parkinson's disease patients. Armed with this knowledge, researchers can identify specific targets for diagnosis and treatment.

29 Mar 2016

Doctors now have better tool to assess individual kidney function

Doctors now have a much-improved tool to assess individual kidney function, thanks to the work of an international team led by University of Saskatchewan medical imaging specialists Drs. Carl and Michal Wesolowski.

21 Mar 2016

Distinct brain networks support retrieval of old and recent memories

When we remember events which occurred recently, the hippocampus is activated. This area in the temporal lobe of the brain is a hub for learning and memory. But what happens, if we try to remember things that took place years or decades ago? Neuroscientists at the Ruhr-University Bochum and the Osaka University have been able to give some answers to this question.

16 Mar 2016

Oral pill could improve breast cancer diagnostic techniques

The ongoing debate about breast cancer diagnostics has left many women confused — particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps but cannot conclusively pinpoint which ones are cancerous. To help resolve this uncertainty, researchers have developed a pill that could improve imaging techniques so that only cancerous tumors light up.

15 Mar 2016

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

The Kircher laboratory at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy and theranostics.

4 Mar 2016

Molecular Imaging News and Research

PET imaging can help identify autoimmune inflammation in MS

PET/CT imaging technique may provide way to break perpetual cycle of alcohol abuse

Novel radioimmunotherapy may help cure colorectal cancer

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

University of Arizona selects Cubresa’s NuPET scanner for cancer research

Small lipid nanocarrier may deliver chemotherapeutic drug more efficiently to brain tumor cells

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

‘Together we are stronger’ - partnership at the heart of expansion plans to revolutionise medical imaging services

Ga-68 DOTATATE PET/CT scans more effective than current imaging standard for detecting NETS

Snapshots of NMDA receptor activation may help in novel drug design

Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

Transforming MR images into body composition measurements: an interview with Olof Leinhard

Scientists discover Hobit, Blimp1 genes that fight disease-causing pathogens

Researchers examine neuropsychological effect in ecstasy users

Structure of fibril protein could lead to specific targets for diagnosis, treatment of Parkinson's disease

Doctors now have better tool to assess individual kidney function

Distinct brain networks support retrieval of old and recent memories

Oral pill could improve breast cancer diagnostic techniques

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News